简介
Michael Brainin, MD PhD Dr(hons) FESO FAHA FEAN FWSO
Emeritus Professor of Neurology at the Danube University Krems, Founding Chair of the Department of Clinical Neurosciences and Preventive Medicine (2000-2019). Director and Chair of the Department of Neurology at the University Clinic Tulln, Austria (1994-2016)
Co-founder of the national stroke unit network and founding president of the Austrian Stroke Society.
President of the European Stroke Organisation (2012-2014) and President of the World Stroke Organisation (2018-2020).
His publications are focused on stroke care and stroke prevention. H index 65, >50.000 citations, over 1.000 invited lectures, editor of three textbooks on Stroke Medicine.
He currently acts or previously has acted as Board Member of the European Academy of Neurology and was Scientific Chairman of its forerunner organisation, the European Federation of Neurological Societies. He received several awards, honorary doctorates and honorary memberships from scientific societies, among them the Marinescu Award of the Romanian Neurological Society, honorary membership of the French Neurological Society, the Presidential award of the European Stroke Organisation, The Leadership Award of the World Stroke Organisation, and the Daniel Lackland Award in Diplomacy and Advocacy for Population Hypertension Risk of the World Hypertension League. In 2024 he was elected as member of the European Academy of Sciences and Arts as well as member of the Academia Europaea.
He is or has previously acted as Senior Editorial Consultant for ‚Stroke’, Associate Editor of the European Journal of Neurology and member of the editorial boards of Neuroepidemiology, International Journal of Stroke, and The Journal of Neurological Sciences. He currently is editor-in-chief of the journal Brain and Heart.
Selection of recent publications:
1. Polypill and RiskOMeter to Prevent StrOke and CogniTive ImpairmEnt in Primary Health Care (PROMOTE) Randomized Clinical Trial: Rationale and Design.
Martins SO, Brainin M, Anderson CS, Bath PM, Hankey GJ, Sposato LA, Pille A, Pontes-Neto OM, Sampaio Silva G, Nasi LA, Souza DO, Feigin VL, Lopes RD, Berwanger O, Pires AP, Secchi TL, Teló BJ, Santos FP, Radin J, Ellwanger J, Martins MO, Pereira DA, Quadros FW, Silva LV, Gonçalves MR, Mantovani GP, Ceretta M, Bastianello JE, Andrade GB, Schirmer C, Zimmer AR, Zimmer ER, Rodrigues M, Falavigna M; World Stroke Organization’s Cut Stroke in Half Project.
Neuroepidemiology. 2025 Aug 23:1-16. doi: 10.1159/000547359. Online ahead of print.
PMID: 40875725
Item in Clipboard
2. CREGS-2 - A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.
Vosko MR, Sanak D, Do Y, Vatanagul JS, Roushdy T, Bornstein N, Vester JC, Brainin M.
Int J Stroke. 2025 Aug 24:17474930251375439. doi: 10.1177/17474930251375439. Online ahead of print.
PMID: 40851188
Item in Clipboard
3. Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study.
Homberg V, Jianu DC, Stan A, Strilciuc Ș, Chelaru VF, Karliński M, Brainin M, Heiss WD, Muresanu DF, Enderby PM.
Stroke. 2025 Apr;56(4):937-947. doi: 10.1161/STROKEAHA.124.049834. Epub 2025 Feb 17.
PMID: 39957612 Free PMC article. Clinical Trial.
Item in Clipboard
4."Spanish flu," encephalitis lethargica, and COVID-19: Progress made, lessons learned, and directions for future research.
Brainin M, Teuschl Y, Gelpi E.
Eur J Neurol. 2024 May 14:e16312. doi: 10.1111/ene.16312. Online ahead of print.
PMID: 38745394
5.
Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review.
Feigin VL, Martins SC, Brainin M, Norrving B, Kamenova S, Giniyat A, Kondybayeva A, Aldyngurov DK, Bapayeva M, Zhanuzakov M, Hankey GJ.
Eur J Neurol. 2024 Mar;31(3):e16157. doi: 10.1111/ene.16157. Epub 2023 Nov 27.
PMID: 38009814
6.
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.
Feigin VL, Owolabi MO; World Stroke Organization–Lancet Neurology Commission Stroke Collaboration Group.
Lancet Neurol. 2023 Dec;22(12):1160-1206. doi: 10.1016/S1474-4422(23)00277-6. Epub 2023 Oct 9.
PMID: 37827183 Review.
7.
Time to revise primary prevention guidelines for stroke and cardiovascular disease.
Brainin M; World Stroke Organization; Grisold W; World Federation of Neurology; Hankey GJ, Norrving B, Feigin VL.
Lancet Neurol. 2022 Aug;21(8):686-687. doi: 10.1016/S1474-4422(22)00264-2.
PMID: 35841903 No abstract available.
8. Polypill: Benefits Seen for Stroke and Other Outcomes.
Brainin M, Teuschl Y, Martins S.
Stroke. 2022 Aug;53(8):2695-2701. doi: 10.1161/STROKEAHA.122.037313. Epub 2022 Jun 21.
PMID: 35726621
